PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Clearing the Path Forward for Cancer-Associated VTE Treatment: The Role of Direct Oral Anticoagulants in Canadian Practice
Visit https://www.peervoice.com/RGZ860 to view the entire programme with slides. After completing “Clearing the Path Forward for Cancer-Associated VTE Treatment: The Role of Direct Oral Anticoagulants in Canadian Practice”, participants will be able to: Discuss the latest evidence with direct oral anticoagulants (DOACs) for the management of cancer-associated venous thromboembolism (VTE); and Outline optimal clinical use of DOACs in cancer-associated VTE, based on the data and recent guideline recommendations.